DK1406902T3 - Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander - Google Patents

Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander

Info

Publication number
DK1406902T3
DK1406902T3 DK02744532T DK02744532T DK1406902T3 DK 1406902 T3 DK1406902 T3 DK 1406902T3 DK 02744532 T DK02744532 T DK 02744532T DK 02744532 T DK02744532 T DK 02744532T DK 1406902 T3 DK1406902 T3 DK 1406902T3
Authority
DK
Denmark
Prior art keywords
sup
hexahydroazepino
indolines
indoles
receptor ligands
Prior art date
Application number
DK02744532T
Other languages
English (en)
Inventor
Arthur Glenn Romero
Jian-Min Fu
Jeanette Kay Morris
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1406902T3 publication Critical patent/DK1406902T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK02744532T 2001-07-13 2002-07-10 Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander DK1406902T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30530501P 2001-07-13 2001-07-13

Publications (1)

Publication Number Publication Date
DK1406902T3 true DK1406902T3 (da) 2006-01-30

Family

ID=23180257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02744532T DK1406902T3 (da) 2001-07-13 2002-07-10 Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander

Country Status (11)

Country Link
US (1) US7022694B2 (da)
EP (1) EP1406902B1 (da)
JP (1) JP2005522408A (da)
AT (1) ATE307133T1 (da)
BR (1) BR0211140A (da)
CA (1) CA2452610A1 (da)
DE (1) DE60206762T2 (da)
DK (1) DK1406902T3 (da)
ES (1) ES2250667T3 (da)
MX (1) MXPA04000358A (da)
WO (1) WO2003006466A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539704A1 (en) * 2002-08-20 2005-06-15 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
EP1537115B1 (en) * 2002-08-29 2008-05-28 Schering Corporation Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
CN102329267A (zh) 2004-02-25 2012-01-25 伊莱利利公司 作为5-HT2C受体激动剂的6-取代的2,3,4,5-四氢-1H-苯并［d］氮杂䓬
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
WO2007028131A1 (en) 2005-09-01 2007-03-08 Eli Lilly And Company 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
JP5249031B2 (ja) 2005-09-01 2013-07-31 イーライ リリー アンド カンパニー ５−ＨＴ２Ｃ受容体アゴニストとしての６−Ｎ結合型へテロ環置換された２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
WO2007028082A1 (en) 2005-09-01 2007-03-08 Eli Lilly And Company 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
BRPI0615048A2 (pt) 2005-09-01 2010-03-30 Lilly Co Eli composto, composição farmacêutica, e, uso de um composto
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
CN106488702A (zh) 2014-05-05 2017-03-08 曹正兵 抗菌表面涂层
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE
EP3753924A1 (en) * 2019-06-18 2020-12-23 AnaMar AB New tricyclic 5-ht2 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling
AU687255B2 (en) 1994-09-14 1998-02-19 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
JP2001514631A (ja) 1997-03-07 2001-09-11 ノボ ノルディスク アクティーゼルスカブ ４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用
AU751414B2 (en) 1998-03-31 2002-08-15 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives for therapeutic use
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi

Also Published As

Publication number Publication date
DE60206762D1 (de) 2006-03-02
MXPA04000358A (es) 2004-05-04
US7022694B2 (en) 2006-04-04
EP1406902A1 (en) 2004-04-14
JP2005522408A (ja) 2005-07-28
EP1406902B1 (en) 2005-10-19
WO2003006466A1 (en) 2003-01-23
US20030060458A1 (en) 2003-03-27
DE60206762T2 (de) 2006-07-13
ATE307133T1 (de) 2005-11-15
ES2250667T3 (es) 2006-04-16
BR0211140A (pt) 2005-10-25
CA2452610A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
MXPA04000507A (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y uso terapeutico.
NO20026064D0 (no) Nye forbindelser
SE0300119D0 (sv) Novel compounds
TW200613243A (en) Novel compounds
ATE316083T1 (de) Adamantanderivate
SE0103836D0 (sv) Novel compounds
DK1458713T3 (da) Indolinonderivater anvendelige som proteinkinaseinhibitorer
AU2003228770A1 (en) Substituted pyrazolopyrimidines
SI1506185T1 (sl) Spojine in njihova uporaba kot inhibitorji 5-HT
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
DK1406902T3 (da) Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE60230424D1 (en) Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
MY138826A (en) 2,7-substituted indoles
DE60208694D1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
WO2003097597A3 (fr) Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
ATE274515T1 (de) Pyrazolopyridinderivate
IL188927A0 (en) Aryloxy quinolines and uses thereof as 5-ht6 modulators
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten